Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Designed for high-throughput genomic analysis, the laboratory enables accurate, consistent, and scalable testing, delivering high standards of reporting excellence
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
33rd lab in Thyrocare’s expanding network to bring advanced, affordable diagnostic services across the Kashmir Valley
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Subscribe To Our Newsletter & Stay Updated